摘要 |
Identifying agents (A) for detection or treatment of specified conditions comprises incubating test compound with BNPI or DNPI (brain or differentiation-associated sodium-dependent inorganic phosphate transporter), or related proteins, nucleic acids or cells (and/or cell preparations), then measuring binding of test compound or some functional parameter altered by binding. - Identifying agents (A) for detection or treatment of specified conditions comprises incubating test compound with BNPI or DNPI (brain or differentiation-associated sodium-dependent inorganic phosphate transporter), or related proteins, nucleic acids or cells (and/or cell preparations), then measuring binding of test compound or some functional parameter altered by binding. (A) is incubated with one or more of BNPI or DNPI, or 7 specified proteins, all fully disclosed in the specification; proteins with at least 90% similarity; proteins encoded by 7 specified nucleic acid sequences all fully disclosed in the specification, by sequences with at least 90% similarity, by sequences that hybridize to them (or their antisense sequences) under stringent conditions, or fragments of the proteins with at least 10, preferably 20, amino acids. - An INDEPENDENT CLAIM is also included for compounds identified by the new method. - ACTIVITY - Ophthalmological; Auditory; Neuroleptic: Antimanic; Antidepressant; Cerebroprotective; Neuroprotective; Analgesic; Anorectic; Anticonvulsant; Antiparkinsonian; Vasotropic; Antiemetic; Antiarthritic; Tranquilizer; Virucide; Antibacterial; Protozoacide; Antiinflammatory; Cardiant; Hypotensive; Antiasthmatic; Immunosuppressive; Antidiabetic; Antialcoholic; Anti-HIV; Nootropic; Antiallergic. No details of tests for any of these activities are given. - MECHANISM OF ACTION - None given. |